Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Hemostasis clinical trials

3 of 8 indexed Hemostasis trials are currently recruiting.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Hemostasis: 8 US clinical trials tracked, 3 recruiting.

Hemostasis is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is United Health Products, running 1 of these trials.

Enrollment posture brief

Registry condition hemostasis

OPEN 3 | RECR 38% | LATE 0 | EARLY 0 | RANK #2176 | SPON 1

Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)

Activity, Motor75%Achalasia50%Hemostasis (this)38%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Hemostasis

Hemostasis lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hemostasis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hemostasis is recruiting below its size-band peers.

    3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Hemostasis trials is spread across many organizations.

    United Health Products accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Hemostasis enrolment sits around 236 participants.

    Median target enrolment is 236 among the 8 trials that report a genuine target (sentinel values excluded). 2 of those (25%) plan for fewer than 100 participants.

  4. Hemostasis splits between interventional and observational designs.

    5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Hemostasis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Endoscopic clip placement in the gastrointestinal tract. Device
1 trials
Surgicel Device
1 trials
HemoStyp Device
1 trials
hm-P bandage Device
1 trials
Volta System Device
1 trials
SURGICEL Original Device
1 trials
ETHIZIA Device
1 trials
Vascular closure with LockeT device Device
1 trials

US sites by state

Facility locations filed on Hemostasis trials. A trial with sites in several states counts in each.

New York 4 trials
Missouri 2 trials
California 2 trials
Utah 1 trials
Texas 1 trials
Tennessee 1 trials
New Jersey 1 trials
New Hampshire 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hemostasis page

8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hemostasis condition card totals 8 registered trials; most-linked intervention Endoscopic clip placement in the gastrointestinal tract.; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.